Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ONTXW - Onconova Therapeutics Inc - Warrants (01/08/2021)

Previous close
0.0671
0   0%

Share volume: 415,931
Last Updated: Fri 23 Jul 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
57%
Profitability 68%
Dept financing 0%
Liquidity 0%
Performance 75%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.07
P/E Ratio 
0.00
DAY RANGE
$0.06 - $0.10
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
78.431 M
YIELD 
N/A
SHARES OUTSTANDING 
3.192 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Steven Fruchtman
Region: US
Website: www.onconova.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Recent news